# Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

> **NCT00865592** · PHASE3 · TERMINATED · sponsor: **Phenomix** · enrollment: 450 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Type 2 Diabetes

## Interventions

- **DRUG:** dutogliptin

## Key facts

- **NCT ID:** NCT00865592
- **Lead sponsor:** Phenomix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2011-01
- **Final completion:** 2011-03
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2010-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865592, "Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00865592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*